Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross
about
A HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparumPfCRT and its role in antimalarial drug resistanceA genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaA process similar to autophagy is associated with cytocidal chloroquine resistance in Plasmodium falciparumMetabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolismPfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockersChlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT.Analysis of malaria parasite phenotypes using experimental genetic crosses of Plasmodium falciparum.The landscape of inherited and de novo copy number variants in a Plasmodium falciparum genetic cross.Malaria drug resistance is associated with defective DNA mismatch repair.Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine.PfCRT-mediated drug transport in malarial parasites.Analysis of chloroquine resistance transporter (CRT) isoforms and orthologues in S. cerevisiae yeastPlasmodium falciparum chloroquine resistance transporter is a H+-coupled polyspecific nutrient and drug exporter.Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter.Degrees of chloroquine resistance in Plasmodium - is the redox system involved?Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum.Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.Quantification of multiple infections of Plasmodium falciparum in vitroPlasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.Optimized protocols for improving the likelihood of cloning recombinant progeny from Plasmodium yoelii genetic crosses.Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum.Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.To kill or not to kill, that is the question: cytocidal antimalarial drug resistance.Function of resistance conferring Plasmodium falciparum chloroquine resistance transporter isoforms.Genetic linkage analyses redefine the roles of PfCRT and PfMDR1 in drug accumulation and susceptibility in Plasmodium falciparum.Purified Plasmodium falciparum multi-drug resistance protein (PfMDR 1) binds a high affinity chloroquine analogue.Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites.SNP genotyping identifies new signatures of selection in a deep sample of West African Plasmodium falciparum malaria parasitesEmerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
P2860
Q27861949-F0CF5D3B-6880-4E0D-9EC4-9410A7C3A808Q27861957-C8499612-BE3A-49CA-92C1-A389AFD4E8B8Q28031418-1A7F39EC-7EB1-4E21-A4AE-A36D64D30E9BQ28535307-2C7B29FF-16D2-4918-9146-67AA7B73355FQ28538247-2F5FF4A2-832E-4443-8D11-146290633977Q28833540-D05901AA-4F8C-4F21-A193-C0F7B8567687Q33636449-EEF9D9D8-0842-499A-8204-A8DB3C4CA07AQ33691907-3CD6FBE8-0DDE-41C7-8A73-AA95AFEAFC04Q34026930-A021B0ED-FDE8-40C2-B764-5431352B7C9FQ34785704-18F879B5-D793-4D9F-A1E3-2A213E621A3FQ35004539-A22DD04A-B8EE-42B3-BCD7-CFC571E4948FQ35069586-59062BB0-659F-432C-928D-EB24FD1874ECQ35163958-AD2672C6-D200-4323-9101-D36BC6B12832Q35212623-30DA0B56-AF5B-43E7-815E-2B323978A1ECQ35684833-429C0A9C-2191-43C0-8D01-2DCA5981BE2CQ35879787-4C3446C4-CE8B-4DA3-8B12-0BC0259CC6ABQ36072626-6EFA9D07-BBE9-4AB0-8718-41F8F0DBD033Q36093316-AFCB386B-7F7B-40F1-A5A9-C3849537F99FQ36269058-827571BA-4167-40BB-ABFD-D0A3D3886427Q36276918-BF26314A-DA7E-48DB-86DD-6D5159FA74A9Q36284126-0B28716A-AC01-40C9-B1EA-3C18F756F4A0Q36353639-D543EDD4-DCFC-4A3E-A97D-A7A66420F431Q36378251-11A46653-C616-4465-82B1-36C4426D744BQ36488172-BA698985-8D8E-4890-84CB-B045701D5248Q36904205-7DE12E61-8FB8-4D69-897A-90D57595E505Q37350934-88F38C4F-161D-42F5-9027-962CFC116615Q37979631-1E74E1F2-DC06-4538-B3A7-5DE99D0B2518Q38670231-E6935044-DEF4-40B9-BDB7-B643AD372BA9Q41925707-EE3BC331-9721-4B8C-9EE7-B0B186AD3C78Q41931489-3281376F-A6D3-4096-9463-53EABA45F56EQ41935640-1CA262CA-0808-4B43-9BD4-7B292892F532Q42111174-9334B434-2FDF-4F64-9796-44E9AA8C3E8EQ42424354-BF18A9C6-D747-4FC3-95A4-7A021FA7214DQ56342194-322E2151-20D1-453D-AA78-ED10AA25D49B
P2860
Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross
@en
type
label
Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross
@en
prefLabel
Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross
@en
P2093
P2860
P1476
Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross
@en
P2093
Bingbing Deng
Drew Thacker
Jigar J Patel
John C Tan
Joseph M Gonzales
Lisa Checkley
Michael T Ferdig
Paul D Roepe
Perri Pleeter
Roland A Cooper
P2860
P304
P356
10.1111/J.1365-2958.2010.07366.X
P407
P577
2010-09-29T00:00:00Z